Letter to the Editor regarding "Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium"

被引：0
|
作者：
Blankfield, Robert P. [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Berea, OH USA
来源：
AMERICAN HEART JOURNAL | 2013年 / 166卷 / 03期
关键词：
D O I：
10.1016/j.ahj.2013.06.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E9 / E9
页数：1
相关论文
共 47 条
  • [21] Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment
    Liu, Nanjun
    Tengstrand, Elizabeth A.
    Chourb, Lisa
    Hsieh, Frank Y.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 279 (03) : 467 - 476
  • [22] STANDARDIZATION OF DEFINITIONS AND CRITERIA FOR CAUSALITY ASSESSMENT OF ADVERSE DRUG-REACTIONS - DRUG-INDUCED BLOOD CYTOPENIAS - REPORT OF AN INTERNATIONAL CONSENSUS MEETING
    BENICHOU, C
    CELIGNY, PS
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (03): : 257 - 262
  • [23] Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association-cardiac safety research consortium cosponsored think tank
    Seifert, Harry A.
    Malik, Raleigh E.
    Bhattacharya, Mondira
    Campbell, Kevin R.
    Okun, Sally
    Pierce, Carrie
    Terkowitz, Jeffrey
    Turner, J. Rick
    Krucoff, Mitchell W.
    Powell, Gregory E.
    AMERICAN HEART JOURNAL, 2017, 194 : 107 - 115
  • [24] Troponin measurements during drug development-considerations for monitoring and management of potential cardiotoxicity: An educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration
    Newby, L. Kristin
    Rodriguez, Ignacio
    Finkle, John
    Becker, Richard C.
    Hicks, Karen A.
    Hausner, Elizabeth
    Chesler, Ruth
    Harper, Courtney
    Targum, Shari
    Berridge, Brian R.
    Lewis, Eric
    Walker, Dana B.
    Dollery, Colin
    Turner, J. Rick
    Krucoff, Mitchell W.
    AMERICAN HEART JOURNAL, 2011, 162 (01) : 64 - 73
  • [25] Chronic Drug-Induced Liver Injury from Labetalol during the Postpartum Period: A Case Report
    Lee, Bruce
    Xiong, Suriya
    Westen, Elizabeth A.
    Warner, Julie Ann
    AJP REPORTS, 2024, 14 (01): : E43 - E47
  • [26] Multiple drugsDrug-induced liver injury, aggravation of drug-induced liver injury and increased blood pressure: case report
    Reactions Weekly, 2023, 1962 (1) : 285 - 285
  • [27] MICROCOMPUTER-AIDED SYSTEM FOR ELECTROCARDIOGRAMS AND BLOOD-PRESSURE ANALYSIS DURING DRUG-INDUCED TRANSIENT PERIODS
    YOUNG, MS
    LIN, KW
    LIN, MT
    PHARMACOLOGY, 1992, 44 (04) : 215 - 224
  • [28] Response to a letter to the editor titled: Are observed upper airway obstruction patterns during drug-induced sedation endoscopy dose-dependent?
    Chang, Edward T.
    Fernandez-Salvador, Camilio
    Capasso, Robson
    Camacho, Macario
    SLEEP AND BREATHING, 2018, 22 (01) : 189 - 190
  • [29] Response to a letter to the editor titled: Are observed upper airway obstruction patterns during drug-induced sedation endoscopy dose-dependent?
    Edward T. Chang
    Camilio Fernandez-Salvador
    Robson Capasso
    Macario Camacho
    Sleep and Breathing, 2018, 22 : 189 - 190
  • [30] Letter to the editor regarding manuscript "Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo: Rationale and methodology behind out-of-hospital cardiac arrest antiarrhythmic drug trial"
    Iannone, Primiano
    AMERICAN HEART JOURNAL, 2014, 168 (04)
12345